Host defense in cryptococcosis. III. In vivo alteration of immunity
- 1 January 1979
- journal article
- research article
- Published by Springer Nature in Mycopathologia
- Vol. 69 (3) , 171-178
- https://doi.org/10.1007/bf00452831
Abstract
The present studies utilize an inbred mouse model to evaluate the adoptive transfer of spleen cells to augment immunity against Cryptococcus neogormans. Protection against cryptococcosis was transferred using spleen cells obtained from mice surviving cryptococcosis. These spleen cell donors had no detectable anticryptococcal antibody. Also, treatment with antimouse-thymocyte globulin ablated dermal hypersensitivity reactions of immunized mice, and shortened survival in both immunized and unimmunized mice. These in vivo studies further support a major role for cell-mediated immunity in host defense against experimental cryptococcosis.This publication has 22 references indexed in Scilit:
- Host defense in cryptococcosisCellular Immunology, 1978
- Host Defense in CryptococcosisInternational Archives of Allergy and Immunology, 1978
- The Role of Late Complement Components and the Alternate Complement Pathway in Experimental CryptococcosisExperimental Biology and Medicine, 1973
- Phagocytosis of latex particles in vitro: Effects of antilymphocyte and antithymocyte serumCellular and Molecular Life Sciences, 1973
- Intradermal Immune Responses to a Schistosomal Egg Antigen During Experimental Murine Schistosoma mansoni InfectionExperimental Biology and Medicine, 1972
- Serology of Human CryptococcosisAnnals of Internal Medicine, 1968
- Cryptococcus neoformans I. Nonencapsulated MutantsJournal of Bacteriology, 1967
- Studies on Heterologous Anti-Lymphocyte Serum in MiceThe Journal of Immunology, 1966
- STUDIES ON HETEROLOGOUS ANTI-LYMPHOCYTE SERUM IN MICE .I. IN VITRO AND IN VIVO PROPERTIES1966